Covered recipient · General Payments record
SAMANTHA M MACKIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$943.48
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $534.28 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $223.56 | 9 |
| Novo Nordisk AS | $81.43 | 4 |
| Lilly USA, LLC | $71.29 | 4 |
| PFIZER INC. | $51.78 | 3 |
| Acerta Pharma LLC | $28.94 | 2 |
| Amneal Pharmaceuticals LLC | $23.28 | 1 |
| Lundbeck LLC | $19.43 | 1 |
| Amgen Inc. | $17.96 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.69 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573588 | CMS |
| ABBVIE INC. | $33.64 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573590 | CMS |
| ABBVIE INC. | $32.55 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573592 | CMS |
| ABBVIE INC. | $17.28 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573594 | CMS |
| ABBVIE INC. | $25.20 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573596 | CMS |
| ABBVIE INC. | $31.75 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573598 | CMS |
| ABBVIE INC. | $26.98 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573600 | CMS |
| ABBVIE INC. | $27.06 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573602 | CMS |
| ABBVIE INC. | $20.41 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107573604 | CMS |
| Amgen Inc. | $17.96 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117316092 | CMS |
| Amneal Pharmaceuticals LLC | $23.28 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139213242 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.50 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104421441 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.44 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105526739 | CMS |
| Lilly USA, LLC | $16.79 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135937170 | CMS |
| Lilly USA, LLC | $21.26 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135902700 | CMS |
| Lilly USA, LLC | $20.15 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135902698 | CMS |
| Lilly USA, LLC | $13.09 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957583 | CMS |
| Lundbeck LLC | $19.43 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146054715 | CMS |
| Novo Nordisk Inc | $20.19 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100384731 | CMS |
| Novo Nordisk Inc | $18.45 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100316800 | CMS |
| Novo Nordisk Inc | $19.03 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100608088 | CMS |
| Novo Nordisk Inc | $23.76 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100507531 | CMS |
| PFIZER INC. | $18.15 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131372553 | CMS |
| PFIZER INC. | $14.89 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132031095 | CMS |
| PFIZER INC. | $18.74 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132087902 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.61 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151185152 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.